From: Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm
Comparator | Spearman’s rank correlation coefficient | |
---|---|---|
End of baseline placebo self-dosing (N = 323) | End of double-blind study-drug use (N = 309) | |
FSFI total | − 0.65b | − 0.66b |
FSFI desire | − 0.58b | − 0.63b |
FSFI arousal | − 0.59b | − 0.64b |
FSFI lubrication | − 0.44b | − 0.41b |
FSFI orgasm | − 0.43b | − 0.55b |
FSFI satisfaction | − 0.67b | − 0.66b |
FSFI pain | − 0.17c | − 0.22b |
GAQ Q1 (satisfaction with arousal) | − 0.46b | − 0.57b |
GAQ Q2 (satisfaction with desire) | − 0.45b | − 0.56b |
GAQ Q3 (benefit from study drug) | − 0.41b | − 0.54b |
WITS-9 total | − 0.55b | − 0.64b |
Number of SSEs per montha | − 0.42b | − 0.32b |